HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption

Microvascular Research

Volumn 81, Issue 2, 2011, Pages 189-197

  Wolfson, Rachel K ^a   Chiang, Eddie T ^b   Garcia, Joe G N ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Acute lung injury; Endothelium; HMGB1; Hsp27; MAP kinase; RAGE

Indexed keywords

ACTIN; ADVANCED GLYCATION END PRODUCT RECEPTOR; CADHERIN; HEAT SHOCK PROTEIN 27; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; RECEPTOR PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL JUNCTION; CONTROLLED STUDY; CYTOSKELETON; DISSOCIATION; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG ENDOTHELIUM; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; STRESS FIBER; VASOCONSTRICTION;

ACTINS; ANTIGENS, CD; ANTIGENS, NEOPLASM; CADHERINS; CAPILLARY PERMEABILITY; CELLS, CULTURED; CYTOSKELETON; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; GAP JUNCTIONS; HMGB1 PROTEIN; HSP27 HEAT-SHOCK PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROFILAMENTS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PULMONARY ARTERY; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STRESS FIBERS;

EID: 79651474104     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.11.010     Document Type: Article

References (47)

1. Andersson U., et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 2000, 192:565-570.
2. Arrigo A.P. Tumor necrosis factor induces the rapid phosphorylation of the mammalian heat shock protein hsp28. Mol. Cell. Biol. 1990, 10:1276-1280.
3. Bierhaus A., et al. Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 2005, 83:876-886.
4. Birukova A.A., et al. Endothelial permeability is controlled by spatially defined cytoskeletal mechanics: atomic force microscopy force mapping of pulmonary endothelial monolayer. Nanomedicine 2009, 5:30-41.
5. Birukova A.A., et al. MAP kinases in lung endothelial permeability induced by microtubule disassembly. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 289:L75-L84.
6. Birukova A.A., et al. Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc. Res. 2004, 67:64-77.
7. Dudek S.M., Garcia J.G. Cytoskeletal regulation of pulmonary vascular permeability. J. Appl. Physiol. 2001, 91:1487-1500.
8. Fiuza C., et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-2660.
9. Gaestel M. MAPKAP kinases-MKs-two's company, three's a crowd. Nat. Rev. Mol. Cell Biol. 2006, 7:120-130.
10. Garcia J.G., et al. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J. Clin. Invest. 2001, 108:689-701.
11. Garcia J.G., et al. Critical involvement of p38 MAP kinase in pertussis toxin-induced cytoskeletal reorganization and lung permeability. FASEB J. 2002, 16:1064-1076.
12. Guo X.H., et al. Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells. APMIS 2006, 114:874-883.
13. Hale K.K., et al. Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J. Immunol. 1999, 162:4246-4252.
14. Hirano S., et al. Endothelial barrier dysfunction caused by LPS correlates with phosphorylation of HSP27 in vivo. Cell Biol. Toxicol. 2004, 20:1-14.
15. Huot J., et al. Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ. Res. 1997, 80:383-392.
16. Hyers T.M., et al. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 1991, 144:268-271.
17. Kim J.Y., et al. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am. J. Physiol. Lung Cell. Mol. Physiol. 2005, 288:L958-L965.
18. Klune J.R., et al. HMGB1: endogenous danger signaling. Mol. Med. 2008, 14:476-484.
19. Kokkola R., et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand. J. Immunol. 2005, 61:1-9.
20. Kostenko S., Moens U. Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell. Mol. Life Sci. 2009, 66:3289-3307.
21. Kotlyarov A., et al. MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat. Cell Biol. 1999, 1:94-97.
22. Landry J., Huot J. Regulation of actin dynamics by stress-activated protein kinase 2 (SAPK2)-dependent phosphorylation of heat-shock protein of 27kDa (Hsp27). Biochem. Soc. Symp. 1999, 64:79-89.
23. Lavoie J.N., et al. Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27. Mol. Cell. Biol. 1995, 15:505-516.
24. Liliensiek B., et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 2004, 113:1641-1650.
25. Mendelsohn M.E., et al. The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein. Proc. Natl Acad. Sci. USA 1991, 88:11212-11216.
26. Millar A.B., et al. Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989, 2:712-714.
27. Mitola S., et al. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J. Immunol. 2006, 176:12-15.
28. Mounier N., Arrigo A.P. Actin cytoskeleton and small heat shock proteins: how do they interact?. Cell Stress Chaperones 2002, 7:167-176.
29. Otero K., et al. Albumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cells. Biochem. J. 2001, 359:567-574.
30. Palumbo R., et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J. Cell Biol. 2004, 164:441-449.
31. Park J.S., et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am. J. Physiol. Cell Physiol. 2003, 284:C870-C879.
32. Park J.S., et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am. J. Physiol. Cell Physiol. 2006, 290:C917-C924.
33. Park J.S., et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J. Biol. Chem. 2004, 279:7370-7377.
34. Phillips P.G., et al. Phallacidin prevents thrombin-induced increases in endothelial permeability to albumin. Am. J. Physiol. 1989, 257:C562-C567.
35. Pichon S., et al. Control of actin dynamics by p38 MAP kinase-Hsp27 distribution in the lamellipodium of smooth muscle cells. J. Cell Sci. 2004, 117:2569-2577.
36. Raman K.G., et al. The role of RAGE in the pathogenesis of intestinal barrier dysfunction after hemorrhagic shock. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G556-G565.
37. Sappington P.L., et al. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002, 123:790-802.
38. Schaphorst K.L., et al. Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L258-L267.
39. Schlueter C., et al. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. Am. J. Pathol. 2005, 166:1259-1263.
40. Sunden-Cullberg J., et al. Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit. Care Med. 2005, 33:564-573.
41. Suter P.M., et al. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 1992, 145:1016-1022.
42. Treutiger C.J., et al. High mobility group 1 B-box mediates activation of human endothelium. J. Intern. Med. 2003, 254:375-385.
43. Ueno H., et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am. J. Respir. Crit. Care Med. 2004, 170:1310-1316.
44. Wang H., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
45. Ware L.B. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin. Respir. Crit. Care Med. 2006, 27:337-349.
46. Wautier J.L., et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J. Clin. Invest. 1996, 97:238-243.
47. Yu M., et al. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 2006, 26:174-179.